Efficacy and safety of nintedanib in elderly patients with progressive fibrosing interstitial lung diseases (ILDs)*

被引：0
|
作者：
Bonella, Autoren F. [1 ]
Moua, T. [2 ]
Okamoto, M. [3 ]
Tomassetti, S. [4 ]
Valenzuela, C. [5 ]
Wuyts, W. [6 ]
Miede, C. [7 ]
Lievens, D. [8 ]
Bendstrup, E. [9 ]
机构：
[1] Univ Duisburg Essen, Zentrum Interstitielle & Seltene Lungenkrankheite, Klin Pneumol,Univ Med Essen, Ruhrlandklin,Univ Klinikum,Westdeutsch Lungenzent, Duisburg, Germany
[2] Mayo Clin Rochester, Div Pulm & Crit Care Med, Rochester, MN USA
[3] Kurume Univ, Sch Med, Div Respirol Neurol & Rheumatol, Dept Internal Med, Kurume, Fukuoka, Japan
[4] Careggi Univ Hosp, Dept Expt & Clin Med, Florence, Italy
[5] Univ Autonoma Madrid, Hosp Univ Princesa, Madrid, Spain
[6] Univ Hosp Leuven, Dept Pulm Med, Unit Interstitial Lung Dis, Leuven, Belgium
[7] Mainanalyt GmbH, Sulzbach, Germany
[8] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[9] Aarhus Univ Hosp, Dept Resp Dis & Allergy, Ctr Rare Lung Dis, Aarhus, Denmark
来源：
PNEUMOLOGIE | 2023年 / 77卷
关键词：
D O I：
10.1055/s-0043-1761002
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Po 256
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [41] Nintedanib in children and adolescents with fibrosing interstitial lung diseases
    Deterding, Robin
    Young, Lisa R.
    DeBoer, Emily M.
    Warburton, David
    Cunningham, Steven
    Schwerk, Nicolaus
    Flaherty, Kevin R.
    Brown, Kevin K.
    Dumistracel, Mihaela
    Erhardt, Elvira
    Bertulis, Julia
    Gahlemann, Martina
    Stowasser, Susanne
    Griese, Matthias
    EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (02)
  • [42] Safety and tolerability of nintedanib in patients with fibrosing interstitial lung diseases: pooled data from four trials
    Valenzuela, Claudia
    Assassi, Shervin
    Bonella, Francesco
    Maher, Toby M.
    Loaiza, Lazaro
    Tschoepe, Inga
    Orsatti, Leticia
    Kolb, Martin
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [43] EFFECTS OF NINTEDANIB ON CIRCULATING BIOMARKERS IN PATIENTS WITH PROGRESSIVE FIBROSING AUTOIMMUNE DISEASE-RELATED INTERSTITIAL LUNG DISEASES
    Maher, T.
    Bonella, F.
    Assassi, S.
    Noth, I.
    Diefenbach, C.
    Ittrich, C.
    Rohr, K.
    Kolb, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 722 - 722
  • [44] Safety and Tolerability of Nintedanib in Patients with Fibrosing ILDs: A Comparison of the INBUILD and INPULSIS Trials
    Martinez, F. J.
    Costabel, U.
    Jenkins, R. G.
    Belperio, J. A.
    Kitamura, H.
    Molina, M. Molina
    Tschoepe, I.
    Coeck, C.
    Haeufel, T.
    Quaresma, M.
    Cottin, V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [45] Continued nintedanib treatment in patients with progressive fibrosing ILDs: interim analysis of INBUILD-ON
    Bonella, F.
    Wuyts, A. W.
    Chaudhuri, N.
    Varone, F.
    Antin-Ozerkis, D.
    Mueller, H.
    Coeck, C.
    Rohr, B. K.
    Cottin, V
    PNEUMOLOGIE, 2022, 76 : S25 - S26
  • [46] Continued nintedanib treatment in patients with progressive fibrosing ILDs: interim analysis of INBUILD-ON
    Wuyts, Wim A.
    Bonella, Francesco
    Chaudhuri, Nazia
    Varone, Francesco
    Antin-Ozerkis, Danielle
    Mueller, Heiko
    Coeck, Carl
    Rohr, Klaus B.
    Cottin, Vincent
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [47] SAFETY AND TOLERABILITY OF NINTEDANIB IN PATIENTS WITH AUTOIMMUNE DISEASE-RELATED INTERSTITIAL LUNG DISEASES (ILDS) IN SUBGROUPS BY SEX AND AGE
    Hoffmann-Vold, A. M.
    Volkmann, E.
    Allanore, Y.
    Assassi, S.
    De Vries-Bouwstra, J.
    Smith, V.
    Tschoepe, I.
    Loaiza, L.
    Kanakapura, M.
    Distler, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 338 - 339
  • [48] Exposure–safety analyses of nintedanib in patients with chronic fibrosing interstitial lung disease
    Ulrike Schmid
    Benjamin Weber
    Celine Sarr
    Matthias Freiwald
    BMC Pulmonary Medicine, 21
  • [49] Continued nintedanib treatment in patients with progressive fibrosing ILDs: interim analysis of INBUILD-ON
    Wuyts, W. A.
    Bonella, F.
    Chaudhuri, N.
    Varone, F.
    Antin-Ozerkis, D.
    Mueller, H.
    Coeck, C.
    Rohr, K. B.
    Cottin, V
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [50] EFFECT OF NINTEDANIB IN PATIENTS WITH PROGRESSIVE FIBROSING ILDS AND PRESERVED LUNG FUNCTION AT BASELINE: FURTHER ANALYSES OF THE INBUILD TRIAL
    Patel, Nina
    Kaner, Robert
    Cerri, Stefania
    Inoue, Yoshikazu
    Mueller, Heiko
    Rohr, Klaus
    Stowasser, Susanne
    Kolb, Martin
    CHEST, 2020, 158 (04) : 1051A - 1052A
12345